The expanding interest in peptides has given rise to a considerable grey market, presenting serious risks to individuals. Such products are often manufactured outside strict regulatory oversight, suggesting such quality and efficacy can be very inconsistent. In addition, these vendors may fail to provide truthful information regarding components… Read More